| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/16/2026 | ±1.7% | +1.5% | over-priced |
| 07/17/2026 | ±2.4% | +9.2% | under-priced |
| 04/16/2026 | ±1.9% | -0.2% | over-priced |
| 02/12/2026 | ±2.5% | -0.5% | over-priced |
| 10/16/2025 | ±2.8% | -2.9% | under-priced |
| 07/17/2025 | ±1.6% | +3.8% | under-priced |
| 04/16/2025 | ±3.5% | +1.1% | over-priced |
| 02/13/2025 | ±1.6% | +1.0% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $9.04 | $12.4B | $1.9B |
| Q2 FY2026 | $10.26 | $12.2B | $2.2B |
| Q1 FY2026 | $7.78 | $11.9B | $1.7B |
| Q4 FY2025 | — | $12.4B | $2.5B |
TRV (TRV) reports in 79 days, with the next report estimated for 01/15/2027. Across the last 8 reports, options priced an average ±2.3% earnings move while the stock actually moved 2.5% on average — the market has been roughly fair on TRV's earnings risk. Fundamentals into the print: EPS up 9.7% year-over-year, revenue down 0.5%. QuantLogix's live 5-factor engine currently reads TRV as a buy at 70/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →